Tipifarnib prevents development of hypoxia-induced pulmonary hypertension
dc.contributor.author | Duluc, L | en_US |
dc.contributor.author | Ahmetaj-Shala, B | en_US |
dc.contributor.author | Mitchell, J | en_US |
dc.contributor.author | Abdul-Salam, VB | en_US |
dc.contributor.author | Mahomed, AS | en_US |
dc.contributor.author | Aldabbous, L | en_US |
dc.contributor.author | Oliver, E | en_US |
dc.contributor.author | Iannone, L | en_US |
dc.contributor.author | Dubois, OD | en_US |
dc.contributor.author | Storck, EM | en_US |
dc.contributor.author | Tate, EW | en_US |
dc.contributor.author | Zhao, L | en_US |
dc.contributor.author | Wilkins, MR | en_US |
dc.contributor.author | Wojciak-Stothard, B | en_US |
dc.date.accessioned | 2020-10-06T12:55:48Z | |
dc.date.available | 2017-01-03 | en_US |
dc.date.issued | 2017-03 | en_US |
dc.identifier.issn | 0008-6363 | en_US |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/67399 | |
dc.format.extent | 276 - 287 | en_US |
dc.relation.ispartof | CARDIOVASCULAR RESEARCH | en_US |
dc.rights | Attribution 3.0 United States | * |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/us/ | * |
dc.subject | Pulmonary hypertension | en_US |
dc.subject | Rho | en_US |
dc.subject | Farnesylation | en_US |
dc.subject | Endothelium | en_US |
dc.title | Tipifarnib prevents development of hypoxia-induced pulmonary hypertension | en_US |
dc.type | Article | |
dc.identifier.doi | 10.1093/cvr/cvw258 | en_US |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000397950900006&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.issue | 3 | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 113 | en_US |